As of 2025-12-23, the Relative Valuation of Abivax SA (ABVX.PA) is (13.96) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 100.00 EUR, the upside of Abivax SA based on Relative Valuation is -114.0%.
The range of the Relative Valuation is (9.46) - (18.45) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.2x - 6.3x | 4.8x |
| Forward P/E multiples | 3.2x - 6.3x | 4.8x |
| Fair Price | (9.46) - (18.45) | (13.96) |
| Upside | -109.5% - -118.5% | -114.0% |
| Date | P/E |
| 2025-12-22 | -39.27 |
| 2025-12-19 | -34.03 |
| 2025-12-18 | -33.21 |
| 2025-12-17 | -32.16 |
| 2025-12-16 | -32.02 |
| 2025-12-15 | -35.46 |
| 2025-12-12 | -36.82 |
| 2025-12-11 | -39.41 |
| 2025-12-10 | -39.14 |
| 2025-12-09 | -35.73 |
| 2025-12-08 | -34.00 |
| 2025-12-05 | -32.09 |
| 2025-12-04 | -31.75 |
| 2025-12-03 | -32.87 |
| 2025-12-02 | -34.58 |
| 2025-12-01 | -36.14 |
| 2025-11-28 | -36.75 |
| 2025-11-27 | -38.05 |
| 2025-11-26 | -38.05 |
| 2025-11-25 | -36.89 |
| 2025-11-24 | -36.55 |
| 2025-11-21 | -34.92 |
| 2025-11-20 | -36.68 |
| 2025-11-19 | -32.94 |
| 2025-11-18 | -33.59 |
| 2025-11-17 | -33.08 |
| 2025-11-14 | -32.06 |
| 2025-11-13 | -30.42 |
| 2025-11-12 | -30.90 |
| 2025-11-11 | -30.63 |
| 2025-11-10 | -31.14 |
| 2025-11-07 | -30.08 |
| 2025-11-06 | -29.81 |
| 2025-11-05 | -28.96 |
| 2025-11-04 | -30.05 |
| 2025-11-03 | -28.35 |
| 2025-10-31 | -30.93 |
| 2025-10-30 | -30.80 |
| 2025-10-29 | -28.48 |
| 2025-10-28 | -27.80 |
| 2025-10-27 | -27.77 |
| 2025-10-24 | -26.95 |
| 2025-10-23 | -26.99 |
| 2025-10-22 | -25.90 |
| 2025-10-21 | -27.09 |
| 2025-10-20 | -26.82 |
| 2025-10-17 | -26.71 |
| 2025-10-16 | -27.60 |
| 2025-10-15 | -28.18 |
| 2025-10-14 | -28.45 |